RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP)

RenovoTAMP is a novel therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. This innovative therapy utilizes our lead product candidate, RenovoGem, (intra-arterial gemcitabine in combination with the proprietary RenovoCath delivery system).* The RenovoCath delivery system is a dual-balloon infusion catheter and delivers chemotherapy directly to the tumor via the arteries (intra-arterially).

Learn more about the RenovoTAMP procedure in the video below.

* RenovoTAMP is additionally compatible with other small molecule chemotherapy drugs

Targeted Delivery

The therapeutic approach of RenovoTAMP is specifically designed for the targeted delivery of chemotherapy via the peripheral vascular system. The two occlusion balloons of RenovoCath enable effective isolation of the vascular site to allow delivery of chemotherapy across the vessel wall to bathe the target in chemotherapy.

Targeted Delivery Works*

Research using the therapeutic approach of the RenovoTAMP platform is promising. In a scientific presentation, patients treated via RenovoTAMP had a survival rate of two years beyond their diagnosis.*

* Patients received radiation therapy prior to RenovoTamp therapy
* R Agah, R Malek, et al. Localized Intra-arterial Gemcitabine: Impact on Survival in Patients with LAPC – A Treatment Program. 2019 Pancreas Club Annual Meeting.

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.

The RenovoRx is cleared for chemotherapeutic drug infusion to selected sites in the peripheral vascular system. Prior to use, please refer to the RenovoRx IFU for complete product indications, warnings, precautions, contraindications, potential adverse effects and detailed instructions for use.